Bradley J Ph D Bolzon Crispr Therapeutics Ag (CRSP) insider trading activity

Bradley J Ph D Bolzon is Director of CRISPR Therapeutics AG. Currently has a direct ownership of 0 shares of CRSP, which is worth approximately $0. The most recent transaction as insider was on Jun 29, 2021, when has been sold 47,536 shares (Common Shares) at a price of $149.03 per share, resulting in proceeds of $7,084,290. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Bradley J PhD Bolzon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 29 2021	SELL Open market or private sale	$7,084,290 $149.03 p/Share	47,536 Reduced 100.0%	0 Common Shares
Jun 28 2021	SELL Open market or private sale	$3,127,359 $153.49 p/Share	20,375 Reduced 100.0%	0 Common Shares
Jun 28 2021	BUY Other acquisition or disposition	-	47,536 Added 50.0%	47,536 Common Shares
Jun 11 2021	SELL Open market or private sale	$1,276,400 $127.64 p/Share	10,000 Reduced 32.92%	20,375 Common Shares
Mar 22 2021	SELL Open market or private sale	$4,017,873 $132.28 p/Share	30,374 Reduced 50.0%	30,375 Common Shares
Mar 01 2021	BUY Other acquisition or disposition	-	13,213 Added 17.86%	60,749 Common Shares
Feb 19 2021	BUY Other acquisition or disposition	-	47,536 Added 50.0%	47,536 Common Shares

Dec 16 2020	SELL Open market or private sale	$1,140,470 $149.12 p/Share	7,648 Reduced 100.0%	0 Common Shares
Oct 29 2020	BUY Other acquisition or disposition	-	18,477 Added 31.25%	40,648 Common Shares
Sep 22 2020	BUY Other acquisition or disposition	-	14,780 Added 40.0%	22,171 Common Shares
Sep 09 2020	BUY Other acquisition or disposition	-	7,391 Added 50.0%	7,391 Common Shares
Nov 19 2019	SELL Open market or private sale	$926,551 $67.41 p/Share	13,745 Reduced 100.0%	0 Common Shares
Oct 30 2019	SELL Open market or private sale	$1,089,690 $51.89 p/Share	21,000 Reduced 60.44%	13,745 Common Shares
May 08 2018	SELL Open market or private sale	$469,166 $50.77 p/Share	9,241 Reduced 21.01%	34,745 Common Shares
Apr 20 2018	BUY Other acquisition or disposition	-	16,262 Added 26.99%	43,986 Common Shares
Dec 22 2017	SELL Open market or private sale	$528,125 $20.3 p/Share	26,016 Reduced 48.41%	27,724 Common Shares
Nov 27 2017	SELL Open market or private sale	$4,048 $20.24 p/Share	200 Reduced 0.37%	53,740 Common Shares
Nov 24 2017	SELL Open market or private sale	$30,456 $20.21 p/Share	1,507 Reduced 2.72%	53,940 Common Shares
Sep 05 2017	BUY Other acquisition or disposition	-	55,447 Added 50.0%	55,447 Common Stock

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

Director

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

Director

BJP